1. Home
  2. HRMY vs SEMR Comparison

HRMY vs SEMR Comparison

Compare HRMY & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • SEMR
  • Stock Information
  • Founded
  • HRMY 2017
  • SEMR 2008
  • Country
  • HRMY United States
  • SEMR United States
  • Employees
  • HRMY N/A
  • SEMR N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • HRMY Health Care
  • SEMR Technology
  • Exchange
  • HRMY Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • HRMY 2.0B
  • SEMR 1.9B
  • IPO Year
  • HRMY 2020
  • SEMR 2021
  • Fundamental
  • Price
  • HRMY $33.18
  • SEMR $13.12
  • Analyst Decision
  • HRMY Buy
  • SEMR Buy
  • Analyst Count
  • HRMY 9
  • SEMR 8
  • Target Price
  • HRMY $47.00
  • SEMR $15.38
  • AVG Volume (30 Days)
  • HRMY 1.2M
  • SEMR 283.9K
  • Earning Date
  • HRMY 10-29-2024
  • SEMR 11-07-2024
  • Dividend Yield
  • HRMY N/A
  • SEMR N/A
  • EPS Growth
  • HRMY N/A
  • SEMR N/A
  • EPS
  • HRMY 2.11
  • SEMR 0.10
  • Revenue
  • HRMY $681,879,000.00
  • SEMR $338,875,000.00
  • Revenue This Year
  • HRMY $24.63
  • SEMR $24.14
  • Revenue Next Year
  • HRMY $18.04
  • SEMR $19.41
  • P/E Ratio
  • HRMY $15.71
  • SEMR $127.37
  • Revenue Growth
  • HRMY 25.83
  • SEMR 20.97
  • 52 Week Low
  • HRMY $22.89
  • SEMR $7.66
  • 52 Week High
  • HRMY $41.61
  • SEMR $16.42
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 47.21
  • SEMR 40.56
  • Support Level
  • HRMY $31.02
  • SEMR $12.61
  • Resistance Level
  • HRMY $41.61
  • SEMR $13.40
  • Average True Range (ATR)
  • HRMY 1.72
  • SEMR 0.35
  • MACD
  • HRMY -0.11
  • SEMR 0.01
  • Stochastic Oscillator
  • HRMY 30.50
  • SEMR 20.50

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: